Kiniksa Pharmaceuticals to Present at Evercore ISI 5th Annual HealthCONx Conference

Rhea-AI Summary

Kiniksa Pharmaceuticals, Ltd. (KNSA) will participate in a fireside chat at the Evercore ISI 5th Annual HealthCONx Conference on November 30, 2022, at 10:05 a.m. ET. A live webcast will be available on Kiniksa's website, with a replay accessible within 48 hours after the event. Kiniksa focuses on developing therapeutic medicines for debilitating diseases with significant unmet medical needs, featuring assets like ARCALYST®, KPL-404, and mavrilimumab, which target underserved conditions and modulate immunological pathways.

HAMILTON, Bermuda, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that management will participate in a fireside chat at the Evercore ISI 5^th Annual HealthCONx Conference on Wednesday, November 30, 2022 at 10:05 a.m. Eastern Time.

A live webcast of Kiniksa’s presentation will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the webcast will also be available on Kiniksa’s website within approximately 48 hours after the event.

About Kiniksa
Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s portfolio assets, ARCALYST^®, KPL-404, and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target underserved conditions, and offer the potential for differentiation. These assets are designed to modulate immunological pathways across a spectrum of diseases. For more information, please visit www.kiniksa.com.

ARCALYST^® is a registered trademark of Regeneron Pharmaceuticals, Inc.

Every Second Counts! ® Kiniksa Investor and Media Contact Rachel Frank (339) 970-9437 rfrank@kiniksa.com

FAQ

What is the date and time of Kiniksa Pharmaceuticals' fireside chat?

Kiniksa Pharmaceuticals' fireside chat is scheduled for November 30, 2022, at 10:05 a.m. Eastern Time.

Where can I watch the Kiniksa Pharmaceuticals fireside chat?

The fireside chat will be accessible via a live webcast on Kiniksa's Investors & Media section of their website.

Will there be a replay of Kiniksa's fireside chat?

Yes, a replay of Kiniksa's fireside chat will be available on their website approximately 48 hours after the event.

What is the focus of Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals focuses on discovering and developing therapeutic medicines for patients with significant unmet medical needs.

What are the key assets of Kiniksa Pharmaceuticals?

Kiniksa's key assets include ARCALYST®, KPL-404, and mavrilimumab, targeting underserved medical conditions.